Riskpilot← Back to searchSign inGet full accessROSTEN LEGESENTER AS
ASActiveOrg 968397923Benneches Vei 6, 7020 TrondheimGeneral medical practice activities · NACE 8621Est. 19931 employees
Revenue 2025
NOK 4,3M
+11% vs 2024
EBITDA margin
41.7%
+3% vs 2024
Equity ratio
85.9%
Financial strength
Net profit 2025
NOK 1,5M
+4% vs 2024
| Revenue | NOK 4,3M | +11% |
| EBITDA | NOK 1,8M | +3% |
| Net profit | NOK 1,5M | +4% |
| Total assets | NOK 5M | +40% |
| Equity | NOK 4,3M | +51% |
| Employees | 1 | — |
Legal name
ROSTEN LEGESENTER AS
Org number
968397923
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
1. august 1993
Share capital
NOK 102 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Company purpose
Legevirksomhet samt alt som naturlig faller innunder. Kan også delta og eie andre selskap. Selv, eller gjennom hel-eller deleide selskaper, eller ved å samarbeide med andre selskaper, å forestå investeringsvirksomhet, herunder kjøp og salg, obligasjoner, selskapsandeler, fast eiendom, samt annen virksomhet som har naturlig sammenheng med dette. Selskapet kan også yte konserninterne tjenester.
Address
Benneches Vei 6, 7020 Trondheim
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 3 406 | 3 882 | 4 293 |
| Staff expenses | −0 | −0 | −635 | −1 091 | −1 276 |
| EBITDA | −6 | −6 | 1 802 | 1 738 | 1 789 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −6 | −6 | 1 802 | 1 738 | 1 789 |
| Net financials | 0 | 0 | 15 | 63 | 82 |
| Profit before tax | −6 | −6 | 1 816 | 1 802 | 1 871 |
| Tax | −0 | −0 | 338 | 397 | −0 |
| Net profit | −6 | −6 | 1 479 | 1 405 | 1 460 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 0 | 0 | 2 196 | 3 584 | 5 016 |
| Equity | −27 | −33 | 1 445 | 2 851 | 4 310 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 27 | 33 | 750 | 734 | 706 |
| Total debt | 27 | 33 | 750 | 734 | 706 |
EBITDA margin
41.7%
This company
15.8%
Market median
+164% vs market
20212025
Equity ratio
85.9%
This company
38.2%
Market median
+125% vs market
20212025
Return on equity
33.9%
This company
18.4%
Market median
+84% vs market
20212025
Net profit margin
34.0%
This company
8.1%
Market median
+320% vs market
20212025
Asset turnover
0.86×
This company
1.12×
Market median
+23% vs market
20212025
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
TL Deputy Member | Deputy Member | 2017 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2023 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ROSTEN LEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thor Leonard Lim Digre | Deputy Member | 0 companies |
| Vegard Berge | Chairman | 0 companies |